Synapse Medicine
VerifiedArtificial intelligence platform to manage drugs prescription.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$112—168m (Dealroom.co estimates Mar 2022.)
Company register number 827466590
Bordeaux Nouvelle-Aquitaine (HQ)
- hard tech
- biotechnology
- woman founder
- core ai
- ai applications
- observatoire deeptech
- biotech, medtech and e-health
- health it
- tech for hospitals & clinics
- tech for medical professionals
- physician support tools
- clinical decision support
- medical imaging
- ai for imaging
- ai agents
- french tech 2030
- medication adherence
- treatment assistance
| EUR | 2018 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | 128 % | 113 % | 16 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | $0.0 | round |
| investor | $0.0 | round | |
| investor investor investor investor investor | $0.0 | round | |
* | $28.0m | Series B | |
| Total Funding | 000k | ||
Related Content
Recent News about Synapse Medicine
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.